The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
China-made HPV vaccine approved in Morocco
Chinese biopharma company Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (Wantai) announced on Wednesday that the Moroccan health authority has approved the bivalent human papillomavirus (HPV) vaccine developed by Xiamen Innovax Biotech Co., Ltd. (Innovax), a wholly-owned subsidiary of Wantai, reported China Securities Journal.
May12,2022
GSK, INNOVAX and Xiamen University to jointly develop next-generation cervical cancer vaccine
INNOVAX, a subsidiary of China's YangShengTang Group, and Xiamen University signed a global alliance partnership agreement on Friday with British pharmaceutical giant GlaxoSmithKline (GSK) in Wavre, Belgium, to develop a next-generation vaccine against human papillomavirus (HPV).
September07,2019
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.